Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 24, 2023Australasian Journal of DermatologyOpen Access

Upadacitinib effectiveness in moderate‐to‐severe atopic dermatitis: A real‐life multicentre and retrospective study

View Full Paper
Ask AI
Bookmark
Share

Authors

FRFrancisco Javier Melgosa RamosHospital Universitario Doctor PesetVGV.A. González-DelgadoHospital Clínico Universitario de ValenciaJMJosé María Sánchez Motilla

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ramos et al. (2023) studied this question.

synapsesocial.com/papers/6a852d640da13985d4cf1f37https://doi.org/10.1111/ajd.14164
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Real-Life Effectiveness and Tolerance of Upadacitinib for Severe Atopic Dermatitis in Adolescents and Adults2023 · 35 citations
  2. 2Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation2023 · 55 citations
  3. 3Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study2023 · 31 citations
  4. 4Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis2022 · 210 citations
  5. 5Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis2016 · 2,107 citations